Suppr超能文献

源自聚乙二醇、反向Tat九肽和沙奎那韦的新型多组分纳米药物表现出联合抗HIV效应。

Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effects.

作者信息

Wan Li, Zhang Xiaoping, Gunaseelan Simi, Pooyan Shahriar, Debrah Olivia, Leibowitz Michael J, Rabson Arnold B, Stein Stanley, Sinko Patrick J

机构信息

Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers University, 160Frelinghuysen Road, Piscataway, New Jersey 08854-0789, USA.

出版信息

AIDS Res Ther. 2006 Apr 24;3:12. doi: 10.1186/1742-6405-3-12.

Abstract

BACKGROUND

Current anti-AIDS therapeutic agents and treatment regimens can provide a dramatically improved quality of life for HIV-positive people, many of whom have no detectable viral load for prolonged periods of time. Despite this, curing AIDS remains an elusive goal, partially due to the occurrence of drug resistance. Since the development of resistance is linked to, among other things, fluctuating drug levels, our long-term goal has been to develop nanotechnology-based drug delivery systems that can improve therapy by more precisely controlling drug concentrations in target cells. The theme of the current study is to investigate the value of combining AIDS drugs and modifiers of cellular uptake into macromolecular conjugates having novel pharmacological properties.

RESULTS

Bioconjugates were prepared from different combinations of the approved drug, saquinavir, the antiviral agent, R.I.CK-Tat9, the polymeric carrier, poly(ethylene) glycol and the cell uptake enhancer, biotin. Anti-HIV activities were measured in MT-2 cells, an HTLV-1-transformed human lymphoid cell line, infected with HIV-1 strain Vbu 3, while parallel studies were performed in uninfected cells to determine cellular toxicity. For example, R.I.CK-Tat9 was 60 times more potent than L-Tat9 while the addition of biotin resulted in a prodrug that was 2850 times more potent than L-Tat9. Flow cytometry and confocal microscopy studies suggest that variations in intracellular uptake and intracellular localization, as well as synergistic inhibitory effects of SQV and Tat peptides, contributed to the unexpected and substantial differences in antiviral activity.

CONCLUSION

Our results demonstrate that highly potent nanoscale multi-drug conjugates with low non-specific toxicity can be produced by combining moieties with anti-HIV agents for different targets onto macromolecules having improved delivery properties.

摘要

背景

目前的抗艾滋病治疗药物和治疗方案能显著改善艾滋病毒阳性患者的生活质量,其中许多患者在很长一段时间内病毒载量检测不到。尽管如此,治愈艾滋病仍然是一个难以实现的目标,部分原因是出现了耐药性。由于耐药性的产生与药物水平波动等因素有关,我们的长期目标是开发基于纳米技术的药物递送系统,通过更精确地控制靶细胞中的药物浓度来改善治疗效果。本研究的主题是研究将艾滋病药物与细胞摄取调节剂结合成具有新型药理特性的大分子缀合物的价值。

结果

由已批准的药物沙奎那韦、抗病毒剂R.I.CK-Tat9、聚合物载体聚乙二醇和细胞摄取增强剂生物素的不同组合制备生物缀合物。在感染了HIV-1毒株Vbu 3的MT-2细胞(一种HTLV-1转化的人淋巴细胞系)中测量抗HIV活性,同时在未感染的细胞中进行平行研究以确定细胞毒性。例如,R.I.CK-Tat9的效力比L-Tat9高60倍,而添加生物素后产生的前药效力比L-Tat9高2850倍。流式细胞术和共聚焦显微镜研究表明,细胞内摄取和细胞内定位的变化,以及SQV和Tat肽的协同抑制作用,导致了抗病毒活性出现意外且显著的差异。

结论

我们的结果表明,通过将针对不同靶点的抗HIV药物部分与具有改善递送特性的大分子结合,可以制备出具有低非特异性毒性的高效纳米级多药缀合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d7/1481600/d5aad5373a8c/1742-6405-3-12-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验